ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #4,048Hybrid

Therapeutic Advances in Gastroenterology

Abbreviation (ISO):THER ADV GASTROENTER
•
Identifier (ISSN):1756-2848(Online)
•
Publisher:SAGE Publications Ltd
Clarivate IF (2026)
3.8↑ +0.4
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Therapeutic Advances in Gastroenterology

WoS Q2
24574.1720183.9620193.5220204.4120214.820224.220233.920243.420253.82026
Annual Impact Factor Metric
Current (2026):3.8
Scopus SJR & RankScopus Q1
1.123
#4,048

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
77

77 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate2.6%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
126articles/year
99.8% Gold OA•67.59% Original Research

Aims & Scope

Therapeutic Advances in Gastroenterology is an open access journal which delivers the highest quality peer-reviewed original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of gastrointestinal and hepatic disorders. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in gastroenterology and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area. The editors welcome original research articles across all areas of gastroenterology and hepatology. The journal publishes original research articles and review articles primarily. Original research manuscripts may include laboratory, animal or human/clinical studies – all phases. Letters to the Editor and Case Reports will also be considered.

Topics Covered (Recognized by AI)
Medicine99.1%Internal medicine94.9%Biology84.2%Pathology74.8%Gastroenterology60.7%Surgery59.1%Genetics55.5%Disease45.7%Chemistry42.3%Biochemistry40.1%Immunology32.4%Psychology28.2%Mathematics26.7%Endocrinology23.6%Psychiatry23.5%Radiology23.3%Statistics23.1%Cancer22.9%Inflammatory bowel disease22.1%Pharmacology20.8%Bioinformatics20.3%Intensive care medicine20.2%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

GASTROENTEROLOGY & HEPATOLOGY

Q2
Rank46/153
IndexSCIE
JCISCIE2026

GASTROENTEROLOGY & HEPATOLOGY

Q2
Rank64/153
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.8
Articles / Year141
Total Citations45
2025
IF3.4
Articles / Year237
Total Citations740
2024
IF3.9
Articles / Year135
Total Citations957
2023
IF4.2
Articles / Year148
Total Citations2,005
2022
IF4.802
Articles / Year128
Total Citations2,022

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,048Scopus Q1SCImago Profile
Scopus Coverage:2008-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
1.123

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
3.85

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,453 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,601
3-Year Documents407
Citable Documents395

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate41.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

GastroenterologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区GASTROENTEROLOGY & HEPATOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Therapeutic Advances in Gastroenterology (abbr: THER ADV GASTROENTER) is a peer-reviewed international scholarly journal in the field of GASTROENTEROLOGY & HEPATOLOGY, published by SAGE Publications Ltd in England. The periodical holds a Journal Impact Factor (JIF) of 3.80, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.123 (Q1), an H-index of 77.

The journal enforces rigorous peer evaluation with an annual output of approximately 126 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,453 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
SAGE Publications Ltd
Publication Language
English
Frequency
Periodic
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
1 OLIVERS YARD, 55 CITY ROAD, LONDON, ENGLAND, EC1Y 1SP

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: fbbc6db3-8101-4bae-ba66-baa48c054a36
Database Updated: 2026-10-01